Gap junction protein connexin43 deregulation contributes to bladder carcinogenesis via targeting MAPK pathway
- 458 Downloads
High expression of connexins was found in a variety of cancers, but their role is still controversial. We investigated whether connexin43 (Cx43) contributed to bladder carcinogenesis through MAPK activation. In this study, we found that Cx43 expression was significantly increased in bladder cancer tissues and cell line. Overexpression of Cx43 in bladder cancer 5637 cells increased cell proliferation, promoted cell cycle progression, and inhibited apoptosis. Western blot showed that JNK and ERK pathways were dramatically activated in Cx43-overexpressed cells. Conversely, knockdown of Cx43 inhibited cell proliferation by increasing apoptosis and causing cell cycle arrest, concomitant with inhibition of JNK and ERK signaling. In addition, JNK and ERK pathways were also activated in bladder cancer tissues. In conclusion, abnormal high expression and cytoplasmic localization of Cx43 contributed to bladder cancer. Inhibition of Cx43 activity could be a potential therapeutic strategy for preventing the progression of bladder cancer.
KeywordsBladder cancer Connexin43 JNK ERK
This work was supported by grants from the scientific research youth fund project of affiliated hospital of Chengde medical University.
Compliance with ethical standards
Conflict of interest
The authors have no conflict of interest to disclose.
- 11.Tittarelli A, Guerrero I, Tempio F, Gleisner MA, Avalos I, Sabanegh S, Ortiz C, Michea L, Lopez MN, Mendoza-Naranjo A, Salazar-Onfray F (2015) Overexpression of connexin 43 reduces melanoma proliferative and metastatic capacity. Br J Cancer 113:259–267. doi: 10.1038/bjc.2015.162 CrossRefPubMedPubMedCentralGoogle Scholar
- 16.Han Y, Zhang PJ, Chen T, Yum SW, Pasha T, Furth EE (2011) Connexin43 Expression Increases in the Epithelium and Stroma along the Colonic Neoplastic Progression Pathway: Implications for Its Oncogenic Role. Gastroenterol Res Pract 2011:561719. doi: 10.1155/2011/561719 CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Qin H, Shao Q, Curtis H, Galipeau J, Belliveau DJ, Wang T, Alaoui-Jamali MA, Laird DW (2002) Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J Biol Chem 277:29132–29138. doi: 10.1074/jbc.M200797200 CrossRefPubMedGoogle Scholar
- 21.Loewenstein WRK, Y. (1966) Intercellular communication and the control of tissue growth :lack of communication between cancer cells. NatureGoogle Scholar
- 22.Poyet C, Buser L, Roudnicky F, Detmar M, Hermanns T, Mannhard D, Hohn A, Ruschoff J, Zhong Q, Sulser T, Moch H, Wild PJ (2015) Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer. J Clin Pathol 68:819–824. doi: 10.1136/jclinpath-2015-202898 CrossRefPubMedPubMedCentralGoogle Scholar
- 23.DavidJ. Panka MBA, andJames W. Mier (2006) Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma. Clin Cancer Res. doi: 10.1158/1078-0432.CCR-05-2539
- 24.Milone MR, Pucci B, Bruzzese F, Carbone C, Piro G, Costantini S, Capone F, Leone A, Di Gennaro E, Caraglia M, Budillon A (2013) Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells. Cell Death Dis 4:e641. doi: 10.1038/cddis.2013.165 CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Liang Z, Wu R, Xie W, Geng H, Zhao L, Xie C, Wu J, Geng S, Li X, Zhu M, Zhu W, Zhu J, Huang C, Ma X, Zhong C, Han H (2015) Curcumin Suppresses MAPK Pathways to Reverse Tobacco Smoke-induced Gastric Epithelial-Mesenchymal Transition in Mice. Phytother Res 29:1665–1671. doi: 10.1002/ptr.5398 CrossRefPubMedGoogle Scholar
- 26.Sun X, Deng QF, Liang ZF, Zhang ZQ, Zhao L, Geng H, Xie DD, Wang Y, Yu DX, Zhong CY (2016) Curcumin reverses benzidine-induced cell proliferation by suppressing ERK1/2 pathway in human bladder cancer T24 cells. Exp Toxicol Pathol 68:215–222. doi: 10.1016/j.etp.2015.12.003 CrossRefPubMedGoogle Scholar